Cannes, France – John McCarthy, VP of digital global at AstraZeneca, and Ali Parsa, founder and CEO of Babylon Health, first met at an event like Cannes. McCarthy saw Parsa as a leader of change in providing easier access and more support. They used it as a wedge to consider how to evolve AZ's commercial practice, particularly in the areas of COPD and asthma.
Parsa said McCarthy and his team are intreprenuers, or insiders who want to make significant change. He pointed to the challenge the industry is up against: all of our effort is focused on the initial sale. The moment the customers takes it out of box, the relationship is finished. "Today when I buy my car," he said, "that's the first day of my relationship with that company."
The partners pointed to what an ongoing relationship really looks like: AZ, Babylon and NHS have the largest deployment of artificial intelligence in the world, supporting 1.5 million people near London.
Babylon's interface starts with a chatbot that takes typical voice queries (like, my stomach is killing me) and prompts users with specific questions and visual tools to help them get closer to a medical diagnosis.
That deep learning engine can give an immediate consultation and quickly set an appoint with a relevant doctor. Once that appointment happens, Babylon can follow up with relevant videos, home prescription delivery, and dosing reminders. In this case, the system is also connected to inhalers and other smart tools provided by AZ.
The program wraps in positive reinforcement and total EHR integration. The latest components actually replicate the user's entire body dynamically to let it predict future health.